Skip to main content

Table 1 Frequency of TLR9 1635A/G and 1486C/T polymorphisms in the HIV positive subjects versus HIV negative controls

From: TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients

  TLR 9 Polymorphism HIV + N (%) HIV-N (%)
1635 AA 13 (26) 8 (27.5)
AG 28 (56) 17 (58.6)
GG 9 (18) 4 (13.8)
1486 CC 7 (14) 5 (17.2)
CT 30 (60) 14 (48.2)
TT 13 (25) 10 (34.5)
1635–1486 AA-CC 6 (12) 5 (17.2)
AA-CT 6 (12) 3 (10.3
AA-TT 1 (2) 0 (0)
AG-CC 1 (2) 0 (0)
AG-CT 24 (48) 11 (37.9)
AG-TT 3 (6) 6 (20.6)
GG-TT 9 (18) 4 (13.8)